We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

88 hedge funds and large institutions have $12.6M invested in Definium Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

879% more call options, than puts

Call options by funds: $9.78M | Put options by funds: $999K

13% more capital invested

Capital invested by funds: $11.1M → $12.6M (+$1.41M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.12% less ownership

Funds ownership: 13.48% → 10.36% (-3.1%)

15% less funds holding

Funds holding: 104 → 88 (-16)

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
88
Holders Change
-16
Holders Change %
-15.38%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
16
Reduced
22
Closed
19
Calls
$9.78M
Puts
$999K
Net Calls
+$8.78M
Net Calls Change
+$1.56M

Top Buyers

1
Two Sigma Investments
Two Sigma Investments
New York
+$447K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$220K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$194K
4
Renaissance Technologies
Renaissance Technologies
New York
+$185K
5
State Street
State Street
Massachusetts
+$76.8K

Top Sellers

1
MFG
Merit Financial Group
Georgia
-$1.19M
2
Millennium Management
Millennium Management
New York
-$549K
3
Goldman Sachs
Goldman Sachs
New York
-$236K
4
Citadel Advisors
Citadel Advisors
Florida
-$205K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
NSIM
26
North Star Investment Management
Illinois
$28.9K +$30.2K +9,092 +27,552%
Bank of America
27
Bank of America
North Carolina
$27.1K -$15.1K -4,535 -35%
Deutsche Bank
28
Deutsche Bank
Germany
$25.4K -$7.87K -2,368 -23%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$14K -$1.86K -561 -11%
Osaic Holdings
30
Osaic Holdings
Arizona
$12.9K -$83 -25 -0.6%
TRCT
31
Tower Research Capital (TRC)
New York
$10K +$5.96K +1,792 +137%
CA
32
Crewe Advisors
Utah
$6.34K – – –
Carson Wealth (CWM LLC)
33
Carson Wealth (CWM LLC)
Nebraska
$6K -$10 -3 -0.2%
National Bank of Canada
34
National Bank of Canada
Quebec, Canada
$4.89K -$665 -200 -11%
TWC
35
TD Waterhouse Canada
Ontario, Canada
$2.54K -$974 -293 -29%
EDRH
36
Edmond de Rothschild Holding
Switzerland
$2.11K – – –
CCA
37
Column Capital Advisors
Indiana
$1.93K – – –
BAM
38
Belpointe Asset Management
Nevada
$1.91K +$47 +14 +2%
PA
39
Parallel Advisors
California
$1.72K +$1.33K +400 +280%
TIM
40
Tortoise Investment Management
New York
$1.27K – – –
AFG
41
Albion Financial Group
Utah
$1.02K – – –
EL
42
EMFO LLC
Florida
$951 – – –
Wells Fargo
43
Wells Fargo
California
$723 +$10 +3 +1%
KTC
44
Kistler-Tiffany Companies
Pennsylvania
$692 – – –
Fidelity Investments
45
Fidelity Investments
Massachusetts
$469 +$226 +68 +85%
IA
46
IFP Advisors
Florida
$360 -$675 -203 -87%
PGAM
47
Princeton Global Asset Management
New Jersey
$317 – – –
FFA
48
Farther Finance Advisors
California
$317 +$332 +100 New
AF
49
Allworth Financial
California
$210 – – –
AF
50
Arrow Financial
New York
$209 – – –
1
2
3 4

DFTX Hedge Fund Activity: Q1 2023 in Review

88 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q1 2023, worth a combined $12.6M — up 13% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of DFTX and 8 opened new positions — a net loss of 11 holders — while 22 trimmed existing stakes and 16 added.

The largest buyer was Two Sigma Investments, adding an estimated $447K. The largest seller was Merit Financial Group, exiting entirely with an estimated $1.19M sold.

  • 88 institutional investors held Definium Therapeutics (DFTX) as of Q1 2023, down from 104 in Q4 2022.
  • Funds reported $12.6M of Definium Therapeutics stock for Q1 2023, up 13% quarter-over-quarter.
  • 8 funds opened new Definium Therapeutics positions in Q1 2023 and 19 closed out, a net change of -11 holders.
  • The largest Definium Therapeutics buyer in Q1 2023 was Two Sigma Investments, an estimated $447K added.
  • The largest Definium Therapeutics seller in Q1 2023 was Merit Financial Group, an estimated $1.19M sold.

Based on aggregated 13F filings for Q1 2023.